Bod Australia (BDA) Short Interest
Bod Australia (ASX:BDA) had 0.03% of shares reported as short positions as of 25 Oct 2021, representing 26,980 shares. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Bod Australia
Bod Australia is an Australian-based company focused on the research, development, and commercialization of cannabis-derived products for therapeutic applications. The company aims to leverage scientific validation and product innovation to establish a strong position in the rapidly evolving medicinal cannabis and health & wellness markets. It typically offers a range of CBD and other cannabinoid-based products, often supported by clinical evidence, targeting both prescription and over-the-counter segments.
Short position
Bod Australia (ASX:BDA) has 0.03% of its shares on issue reported as short positions as of 25 Oct 2021, or about 26,980 shares. Over the past 30 days that figure has fallen 0.15 percentage points, and over 90 days it has fallen 0.07 percentage points. Its highest recorded short interest was 0.30% in September 2019. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Weekly context: The 10 most shorted ASX stocks — Week 35, 2026.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4BDA intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Company
AI-generated research profile of Bod Australia
About
website
Be the first to discuss BDA
Start a research thread or post the first pulse update